Business
줄기세포 치료제
CDMO 사업
R&D
보유기술
보유기술
연구성과
강스템바이오텍은 세포치료제와 오가노이드 기반 플랫폼 기술을 중심으로 과학적 검증과 임상적 가능성을 동시에 갖춘 혁신 치료제를 개발하고 있습니다.
Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulf
01
2019.10
Journal of Tissue Engineering and Regenerative Medicine
Title | Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis |
Title (ISO) | J Tissue Eng Regen Med |
Title (JCR Abbrev.) | J Tissue Eng Regen Med |
Title (Full name) | Journal of Tissue Engineering and Regenerative Medicine |
출판사 | WILEY |
게재년월 | 2019.10 |
ISSN | 1932-6254 |
SCI | SCI |
Author | Yu Y, Yoo SM, Park HH, Baek SY, Kim YJ, Lee S, Kim YL, Seo KW, Kang KS |
총저자수 | 9 |
국가개발연구 과제 | 보복부(HI12C0130) |
제1저자 | 유연실, 유새미 |
논문보기 |